We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+6.28%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.31B
AUM Growth
-$78.9M
Cap. Flow
-$105M
Cap. Flow %
-7.96%
Top 10 Hldgs %
6.88%
Holding
1,081
New
330
Increased
200
Reduced
286
Closed
229

Top Sells

Rank Stock Value
1
MDB icon
MongoDB
MDB
+$7M
2
CRL icon
Charles River Laboratories
CRL
+$6.37M
3
FND icon
Floor & Decor
FND
+$5.83M
4
BRKR icon
Bruker
BRKR
+$5.34M
5
ASAN icon
Asana
ASAN
+$5.32M

Sector Composition

Rank Sector Weight
1 Technology 24.86%
2 Healthcare 21.49%
3 Industrials 12.78%
4 Consumer Discretionary 11.8%
5 Financials 9.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GIC icon
726
Global Industrial
GIC
$1.36B
$245K 0.02%
6,000
-3,100
-34% -$127K
MPAA icon
727
Motorcar Parts of America
MPAA
$265M
$245K 0.02%
+14,341
New +$269K
TCX icon
728
Tucows
TCX
$105M
$244K 0.02%
2,909
-1,272
-30% -$106K
TRST
729
Trustco Bank Corp NY
TRST
$981M
$243K 0.02%
7,286
-4,574
-39% -$152K
LUNA
730
DELISTED
Luna Innovations Incorporated
LUNA
$243K 0.02%
28,827
+11,827
+70% +$106K
AAWW
731
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
$243K 0.02%
+2,580
New +$222K
TFFP
732
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
$240K 0.02%
1,083
-249
-19% -$48.2K
SENEA icon
733
Seneca Foods Class A
SENEA
$1.17B
$239K 0.02%
+4,988
New +$245K
CSII
734
DELISTED
Cardiovascular Systems, Inc.
CSII
$239K 0.02%
+12,714
New +$339K
OLMA icon
735
Olema Pharmaceuticals
OLMA
$991M
$236K 0.02%
+25,169
New +$521K
LPSN icon
736
LivePerson
LPSN
$22.6M
$235K 0.02%
439
+92
+27% +$63.8K
CCRN
737
DELISTED
Cross Country Healthcare
CCRN
$234K 0.02%
+8,445
New +$205K
KRRO icon
738
Korro Bio
KRRO
$148M
$231K 0.02%
899
-782
-47% -$238K
YORW icon
739
York Water
YORW
$515M
$231K 0.02%
4,636
-554
-11% -$26.4K
TECX
740
Tectonic Therapeutic
TECX
$535M
$230K 0.02%
4,975
-1,110
-18% -$63.8K
CWH icon
741
Camping World
CWH
$380M
$229K 0.02%
5,665
-14,579
-72% -$589K
PUMP icon
742
ProPetro Holding
PUMP
$1.27B
$229K 0.02%
28,271
+14,772
+109% +$134K
EPC icon
743
Edgewell Personal Care
EPC
$1.3B
$226K 0.02%
4,943
-8,559
-63% -$345K
AMTB icon
744
Amerant Bancorp
AMTB
$1.17B
$224K 0.02%
6,491
-3,891
-37% -$114K
SFST icon
745
Southern First Bancshares
SFST
$590M
$222K 0.02%
+3,553
New +$209K
CSTE icon
746
Caesarstone
CSTE
$69.8M
$220K 0.02%
19,389
+1,042
+6% +$12.5K
IVVD icon
747
Invivyd
IVVD
$167M
$220K 0.02%
+30,356
New +$789K
CE icon
748
Celanese
CE
$4.77B
$218K 0.02%
+1,300
New +$212K
RCEL icon
749
Avita Medical
RCEL
$136M
$217K 0.02%
18,135
-4,087
-18% -$62.3K
MDGL icon
750
Madrigal Pharmaceuticals
MDGL
$12.5B
$215K 0.02%
+2,535
New +$208K

Similar funds

PDT Partners's Q4 2021 Portfolio in Review

As of Q4 2021, PDT Partners held 1,081 positions worth $1.31B, down 5.7% from $1.39B the previous quarter. Its ten largest holdings account for 6.9% of the portfolio.

PDT Partners withdrew a net $105M in Q4 2021, closing 229 positions and reducing 286 holdings. Its most notable exit was MongoDB, an estimated $7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, PDT Partners opened a new position in Allakos worth $940K.

  • PDT Partners's largest Q4 2021 buy was Allakos: 96,046 shares worth $940K.
  • PDT Partners added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2021, an estimated $5.72M increase.
  • PDT Partners's biggest Q4 2021 reduction was Charles River Laboratories, cutting an estimated $6.37M.
  • PDT Partners fully exited MongoDB in Q4 2021, selling an estimated $7M.
  • PDT Partners's ten largest holdings make up 6.9% of its $1.31B portfolio in Q4 2021.
  • PDT Partners opened 330 new positions and closed 229 in Q4 2021.
  • PDT Partners's portfolio value fell 5.7% quarter-over-quarter to $1.31B.

Based on PDT Partners's 13F filing for Q4 2021, filed 14 Feb 2022.